Description
In the UK, around a third of British children have tooth decay. Just among the under-fives, it's a quarter - a figure that rises significantly in the most deprived areas.
Tooth decay can cause speech development issues, embarrassment for children and in 2023, 15 million school days were missed due to tooth pain or treatment. There’s a financial cost too – in 2023 in England alone tooth extractions under a general anaesthetic cost the NHS £41 million.
And it's totally preventable.
So, how can we stop teeth rotting in the first place? One way initiative announced by the new Labour government is to expand supervised toothbrushing sessions to more children. We find out how these work with Oral Health Team Lead Helen Bullingham who supports nurseries and schools in East Sussex to deliver these programmes.
But what about the evidence to support this intervention? Zoe Marshman, Professor of Dental Public Health at University of Sheffield, explains her findings and dental hygienist and researcher at King's College London Dr Claire McCarthy describes what parents should be doing, in an ideal world, at home.
And finally, what role does sugar play and how can we get consumption down? Dr Nina Rogers from the Population Health Innovation Lab at the London School of Hygiene & Tropical Medicine explains her findings into the impact of the Sugar Drinks Industry Levy introduced in 2018.
Presenter: James Gallagher
Producers: Hannah Robins
Content Editor: Holly Squire
Inside Health is a BBC Wales & West production for Radio 4, produced in partnership with The Open University.
Olympic cyclist Sir Chris Hoy is calling for more prostate cancer testing after he was diagnosed with terminal cancer.
Prostate cancer can often present without symptoms, and for people like Sir Chris, this can mean it isn't diagnosed until it has spread and become incurable. Unlike breast,...
Published 11/12/24
The first drugs to slow Alzheimer's progression have been making headlines around the world. For researchers in the field, the arrival of these two therapies called Lecanemab and Donanemab is testament to decades of advancements in the field of Alzheimer's research because for the first time they...
Published 11/05/24